These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21700265)

  • 1. Complement receptor 1 gene variants are associated with erythrocyte sedimentation rate.
    Kullo IJ; Ding K; Shameer K; McCarty CA; Jarvik GP; Denny JC; Ritchie MD; Ye Z; Crosslin DR; Chisholm RL; Manolio TA; Chute CG
    Am J Hum Genet; 2011 Jul; 89(1):131-8. PubMed ID: 21700265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort.
    Bluett J; Ibrahim I; Plant D; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Pharmacogenomics J; 2014 Apr; 14(2):171-5. PubMed ID: 23856853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Johansson JU; Brubaker WD; Javitz H; Bergen AW; Nishita D; Trigunaite A; Crane A; Ceballos J; Mastroeni D; Tenner AJ; Sabbagh M; Rogers J
    Alzheimers Dement; 2018 Nov; 14(11):1438-1449. PubMed ID: 29792870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.
    Brouwers N; Van Cauwenberghe C; Engelborghs S; Lambert JC; Bettens K; Le Bastard N; Pasquier F; Montoya AG; Peeters K; Mattheijssens M; Vandenberghe R; Deyn PP; Cruts M; Amouyel P; Sleegers K; Van Broeckhoven C
    Mol Psychiatry; 2012 Feb; 17(2):223-33. PubMed ID: 21403675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function.
    Fonseca MI; Chu S; Pierce AL; Brubaker WD; Hauhart RE; Mastroeni D; Clarke EV; Rogers J; Atkinson JP; Tenner AJ
    PLoS One; 2016; 11(2):e0149792. PubMed ID: 26914463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer's disease.
    Kucukkilic E; Brookes K; Barber I; Guetta-Baranes T; ; Morgan K; Hollox EJ
    Hum Genet; 2018 Apr; 137(4):305-314. PubMed ID: 29675612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease.
    Sandri TL; Lidani KCF; Andrade FA; Meyer CG; Kremsner PG; de Messias-Reason IJ; Velavan TP
    Sci Rep; 2018 Jan; 8(1):526. PubMed ID: 29323238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographical distribution of complement receptor type 1 variants and their associated disease risk.
    Lucas Sandri T; Adukpo S; Giang DP; Nguetse CN; Antunes Andrade F; Tong HV; Toan NL; Song LH; Elumalai P; Thangaraj K; Valluri VL; Ntoumi F; Meyer CG; Jose de Messias Reason I; Kremsner PG; Velavan TP
    PLoS One; 2017; 12(5):e0175973. PubMed ID: 28520715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.
    Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3b receptor (CR1) genomic polymorphism in rheumatoid arthritis. Low receptor levels on erythrocytes are an acquired phenomenon.
    Kumar A; Malaviya AN; Sinha S; Khandekar PS; Banerjee K; Srivastava LM
    Immunol Res; 1994; 13(1):61-71. PubMed ID: 7897264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
    Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
    Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease: A case-control study.
    Luo J; Chen S; Wang J; Ou S; Zhang W; Liu Y; Qin Z; Xu J; Lu Q; Mo C; Li S; Qin X
    Gene; 2019 Mar; 688():107-118. PubMed ID: 30529247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of glycosylation on allelic and cell-specific Mr variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor.
    Lublin DM; Griffith RC; Atkinson JP
    J Biol Chem; 1986 May; 261(13):5736-44. PubMed ID: 2939068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of CR1 with Alzheimer's disease: a tentative disease mechanism.
    Hazrati LN; Van Cauwenberghe C; Brooks PL; Brouwers N; Ghani M; Sato C; Cruts M; Sleegers K; St George-Hyslop P; Van Broeckhoven C; Rogaeva E
    Neurobiol Aging; 2012 Dec; 33(12):2949.e5-2949.e12. PubMed ID: 22819390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.